Pfizer Limited (NSE:PFIZER)

India flag India · Delayed Price · Currency is INR
4,004.50
+31.45 (0.79%)
Mar 28, 2025, 3:30 PM IST
-4.75%
Market Cap 183.20B
Revenue (ttm) 22.36B
Net Income (ttm) 6.16B
Shares Out 45.75M
EPS (ttm) 134.53
PE Ratio 29.77
Forward PE n/a
Dividend 35.00 (0.88%)
Ex-Dividend Date Aug 21, 2024
Volume 57,588
Average Volume 35,221
Open 3,970.00
Previous Close 3,973.05
Day's Range 3,954.65 - 4,104.90
52-Week Range 3,865.00 - 6,451.15
Beta 0.22
RSI 37.11
Earnings Date May 29, 2025

About Pfizer

Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers internal medicine and anti-infectives services to hospitals and nursing homes. It serves healthcare... [Read more]

Sector Healthcare
Founded 1950
Employees 1,721
Stock Exchange National Stock Exchange of India
Ticker Symbol PFIZER
Full Company Profile

Financial Performance

In 2023, Pfizer's revenue was 21.93 billion, a decrease of -9.55% compared to the previous year's 24.25 billion. Earnings were 5.51 billion, a decrease of -11.64%.

Financial Statements

News

There is no news available yet.